Evidence map›Paper›PMID 32961751›Full record

ArticleCells2020

FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.

Lorenzo Lafranchi, Erik Müllers, Dorothea Rutishauser, Arne Lindqvist

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lorenzo LafranchiDepartment of Cell and Molecular Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.ORCID 0000-0001-8234-4162
Erik MüllersDepartment of Cell and Molecular Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.ORCID 0000-0002-2176-3248
Dorothea RutishauserDivision of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.ORCID 0000-0003-2303-103X
Arne LindqvistDepartment of Cell and Molecular Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Karolinska Institutet · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells recovering from the G2/M DNA damage checkpoint rely more on Aurora A-PLK1 signaling than cells progressing through an unperturbed G2 phase, but the reason for this discrepancy is not known. Here, we devised a method based on a FRET reporter for PLK1 activity to sort cells in distinct populations within G2 phase. We employed mass spectroscopy to characterize changes in protein levels through an unperturbed G2 phase and validated that ATAD2 levels decrease in a proteasome-dependent manner. Comparing unperturbed cells with cells recovering from DNA damage, we note that at similar PLK1 activities, recovering cells contain higher levels of Cyclin B1 and increased phosphorylation of CDK1 targets. The increased Cyclin B1 levels are due to continuous Cyclin B1 production during a DNA damage response and are sustained until mitosis. Whereas partial inhibition of PLK1 suppresses mitotic entry more efficiently when cells recover from a checkpoint, partial inhibition of CDK1 suppresses mitotic entry more efficiently in unperturbed cells. Our findings provide a resource for proteome changes during G2 phase, show that the mitotic entry network is rewired during a DNA damage response, and suggest that the bottleneck for mitotic entry shifts from CDK1 to PLK1 after DNA damage.

Indexed as

ATPases Associated with Diverse Cellular ActivitiesAurora Kinase ACDC2 Protein KinaseCell Cycle ProteinsCell Line, TumorCyclin B1DNA-Binding ProteinsDNA DamageFibroblastsFlow CytometryFluorescence Resonance Energy TransferG2 Phase Cell Cycle CheckpointsGene Expression RegulationHumansMitosisM Phase Cell Cycle CheckpointsATAD2 protein, humanATPases Associated with Diverse Cellular ActivitiesAURKA protein, humanAurora Kinase ACCNB1 protein, humanCDC2 Protein KinaseCDK1 protein, humanCell Cycle ProteinsCyclin B1DNA-Binding ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1ZinostatinCDK1checkpoint recoveryCyclin B1DNA damageFRETG2mitosismitotic entryPLK1

Identifiers

PMID32961751
PMCPMC7564076
OpenAlexW3087529394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.